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Abstract The stems of Berberis aristata DC. (Berberida-
ceae) are used in the South Asian traditional medicine as a
key ingredient in formulations for eye care, skin diseases,
jaundice, rheumatism and also in diabetes. B. lycium Royle
andB.asiaticaRoxb.aretradedasequivalentsofB.aristata.
Conventional macro-morphology and microscopic exami-
nation does not aid in critically distinguishing the three
species. DNA markers were developed by amplifying and
sequencing the complete internal transcribed spacer region
(ITS1, 5.8S rRNA and ITS2) from the genomic DNA, using
universal primers. The markers developed are efﬁcient and
reliable in authenticating B. aristata, B. asiatica and B. ly-
cium.Theseareusefulasmolecularpharmacognostictoolin
quality control of raw drugs.
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Introduction
Medicinal herbs are moving from fringe to mainstream use
with a greater number of people seeking remedies and
health approaches free from side effects caused by
synthetic chemicals (Dubey et al. 2004). With so much
demand for traditional herbal medicines, it is imperative to
ensure and maintain authenticity of the various botanical
entities used as raw material. However, the conventional
quality assurance tools sometimes have limitations in
critical identiﬁcation of raw materials derived from closely
related species, substitutes or adulterants.
‘Daruharidra’ (in Sanskrit means ‘the wood having
yellow color’) is one such botanical entity that poses
problems in terms of ﬁeld identiﬁcation. Botanically cor-
related to Berberis aristata DC. (Berberidaceae) it has been
used in Ayurveda and Traditional Chinese Medicine for the
past 3,000 years (Anonymous 1999; Sack and Froehlich
1982). In Ayurveda, it forms a key ingredient in prepara-
tion of formulations for eye care, wounds, skin diseases,
jaundice, rheumatism and also in diabetes (Anonymous
1999). The genus Berberis constitutes of spinous shrubs
distributed throughout the Himalayas, from Bhutan to
Kunawar (altitude 6,000–10,000 ft) in India and Sri Lanka
(altitude 6,000–7,000 ft) (Kirtikar and Basu 1995). B.
aristata is a plant species of high trade sourced from
temperate forests. The present annual production and
supply of B. aristata in India is dependent only from the
state of Himachal Pradesh (Ved and Goraya 2008).
In ﬁeld, more than one species of Berberis usually occur
together. The nature of the Berberis species varies with
place and the leaves exhibit great variations (Rao et al.
1998). So, Rao et al. (1999) reported pollen morphologic
studies in solving taxonomic problem in this complex
group. Since harvesting of Berberis spp. takes place during
winter months when the key phenological features for
identiﬁcation are not present, it becomes difﬁcult to dis-
tinguish one species from the other in the ﬁeld. Thus,
species other than B. aristata are also harvested. Since
stems are the parts used it becomes even more challenging
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DOI 10.1007/s13205-010-0001-5to obtain authentic collections and assure quality. As a
result, B. asiatica Roxb. and B. lycium Royle are traded and
used as equivalents/substitutes of B. aristata (Anonymous
2003; Ved and Goraya 2008). Conventional Pharmacog-
nosy techniques based on macro-morphological characters
may not be effective in distinguishing the three species
traded as ‘Daruharidra’. Further, related species may share
similar histological characteristics, making microscopic
examination not so accurate (Yan-Bo et al. 2007).
Different species of the same genus may have totally
different or weaker pharmacological action as compared
with the authentic counterpart (Yip et al. 2007). Therefore,
more objective and deﬁnitive methods are necessary for
identiﬁcation and authentication of herbs. Extracts of
B.aristataaresaidtopossessanti-amebic(Sohnietal.1995),
anti-microbial (Singh et al. 2007), wound healing (Biswas
and Mukherjee 2003), anti-oxidant and anti-hyperglycemic
properties (Singh and Kakkar 2009). B. asiatica has been
reported to have anti-microbial and anti-tumor effects
(Kumar et al. 1998; Singh et al. 2007) while B. lycium is
reported to possess anti-bacterial, anti-diabetic effect and is
also used to treat bleeding piles (Singh et al. 2007; Ahmad
and Alamgeer 2009).
Berberine, an alkaloid is considered to be the active
compound present in Berberis spp. with diverse pharma-
cological effects and is also considered as a nutraceutical
(Saied et al. 2007; Wongbutdee 2009; Affuso et al. 2009).
Since, berberine is present in all the three species of Ber-
beris, i.e., B. aristata, B. lycium and B. asiatica, with
inherent inter and intra species quantitative differences,
phytochemical proﬁling may not reﬂect the exact identity
of the raw drug (Chandraa and Purohita 1980; Srivastava
et al. 2004). The annual trade of Daruharidra including the
substitutes is estimated to be 500–1,000 Metric Tonnes
(Ved and Goraya 2008). According to the WHO general
guidelines for methodologies on research and evaluation of
traditional medicines, ﬁrst step in assuring quality, safety
and efﬁcacy of traditional medicines is correct identiﬁca-
tion (World Health Organization 2000).
DNA-based markers have now become a popular means
for the identiﬁcation and authentiﬁcation of plants because
genetic composition is unique for each individual irrespec-
tive of the physical form and is less affected by age, physi-
ological condition, environmental factors, harvest, storage
andprocessing.DNAextractedfromleaves,stemsorrootsof
a herb all carry the same genetic information and extracted
DNAcanbestoredforlongerdurationastheyarestable(Yip
et al. 2007). Nuclear ribosomal RNA genes and internal
transcribed spacer (ITS) sequences have become favored
markers in evolutionary studies at different taxonomic lev-
els. In recent days, these sequence variations are used to
develop speciﬁc markers for the identiﬁcation and authen-
tication of raw drugs and herbal formulations (Yan-Bo et al.
2007; Balasubramani et al. 2010).
The objective of the present investigation was to develop
molecular markers for distinguishing B. aristata, B. asiatica
and B. lycium based on their nuclear DNA ITS sequence.
Materials and methods
Plant material
Field samples of B. aristata, B. asiatica and B. lycium,
were collected from different geographical locations of
Himachal Pradesh in India. The authenticity of the samples
was conﬁrmed by qualiﬁed taxonomist. Each sample was
assigned a speciﬁc laboratory identiﬁcation number as
Table 1 Details of the Berberis
sp. stem samples used in the
study
The accessions were collected
from different locations of
Himachal Pradesh, India
(HP-latitude 32290N; longitude
75100E)
Si no. Name of the species Place of collection Accession No.
1 B. aristata Taradevi forest, Shimla L/06/10/010
2 Taradevi forest, Shimla L/06/10/011
3 Potter’s hill, Shimla L/08/09/012
4 Shillaru, Shimla L/08/10/008
5 Potter’s Hills, Shimla L/08/10/011
6 B. asiatica Mulshi, Mussoorie L/07/12/001
7 Urla village, Mandi Dt. L/08/03/001
8 Saharan-Nahan Road L/08/09/013
9 Saharan-Nahan road L/08/09/016
10 B. lycium Karol, Manikaran, Kullu Dt. L/06/06/037
11 Kangra, Palmpur L/06/10/008
12 Potter’s hills, Shimla L/08/09/014
13 Shillaru, Kangra L/08/10/009
14 Chail, Solan Dt. L/08/10/010
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123indicated in Table 1. Voucher specimens were deposited in
the Herbarium and Raw Drug Repository (FRLH), Ban-
galore, India.
Chemicals
Tris–HCl, EDTA, NaCl, Cethyltrimethylammonium bro-
mide (CTAB), Polyvinyl pyrrolidone (PVP), b mercap-
toethanol, isopropanol, agarose, boric acid, and ethanol
were purchased from Sigma Chemicals (Sigma-Aldrich,
Bangalore, India). Enzymes (Taq Polymerase and RNase
A), buffer, MgCl2 and dNTPs for PCR ampliﬁcation were
purchased from Bangalore Genei (Bangalore, India).
Genomic DNA extraction
Stem samples of B. aristata, B. asiatica and B. lycium were
cut into small pieces and dried in a dehydrator at 48–50 C
(Hardfacts, Mumbai, India) until a constant dry weight is
obtained. The dried stem pieces were stored at room tem-
perature until use. Total genomic DNA was extracted fol-
lowing the protocol described by Milligan (1998) with
modiﬁcations. The dried stem pieces were ground into
coarse powder in a domestic blender. Approximately,
100 mg of the coarse powder was ground with liquid
nitrogen to a ﬁne powder. Extraction buffer containing 2%
(w/v) CTAB, 1.4 M NaCl, 20 mM EDTA, 100 mM Tris–
HCl (pH 8), 1% (w/v) PVP and 0.2% (v/v) b mercap-
toethanol (pH 7.5–8.0) was added to the powder. The slurry
was incubated at 60 C in a water bath for 60–90 min
followed by extraction using chloroform:isoamyl alcohol
(24:1) (v/v) with centrifugation at 9,000 rpm for 10 min at
4 C. The aqueous phase was collected and the extraction
process was repeated twice. Finally, the DNA was pre-
cipitated from pooled aqueous phase using ice cold ethanol.
Nucleic acid was recovered by centrifugation at 8,000 rpm
for 15 min at 4 C and the pellet was dissolved in TE
buffer (10 mM Tris–Hcl, 1 mM EDTA; pH 8). The con-
taminating RNA was removed by treating with RNase A
(20 lg/lL) for 30 min at 37 C. The quantity and purity of
DNA were checked using UV spectrophotometer by cal-
culating the A260/A280 ratio (Shimadzu, Tokyo, Japan) (Fai
and Ngan 2002). The DNA stock concentration was
maintained at 30–50 ng/lL.
Ampliﬁcation of ITS region
Double-stranded DNA of the complete ITS region (ITS1,
5.8S rRNA gene and ITS2) of the test species was ampli-
ﬁed with the universal primers ITS5 (forward primer;
50 GGAAGTAAAAGTCGTAACAAGG 30) and ITS4
(reverse primer; 50 TCCTCCGCTTATTGATATGC 30)
(White et al. 1990). The primers were custom synthesized
by Bioserve biotechnologies (Hyderabad, India). Ampliﬁ-
cation was carried out in 25 lL reaction volume with
sterile distilled water, 2.5 lL1 0 9 Taq buffer, 2.0 mM
MgCl2, 0.6 mM dNTP mixture, 30 pM of each primer,
1.5 U Taq DNA polymerase and approximately 60 ng of
genomic DNA. PCR was performed in an Eppendorf
Mastercycler Gradient (Hamburg, Germany). The ampliﬁ-
cation proﬁle was 94 C for 4 min followed by 35 cycles of
94 C for 80 s, 60 C for 40 s, 72 C for 80 s with a ﬁnal
extension step at 72 C for 4 min.
PCR products were resolved on 1.2% agarose, 0.59
TBE gels pre-stained with ethidium bromide (0.5 lg/ml).
Simultaneously, 100 bp DNA ladder (Fermentas, Ontario,
Canada) was loaded to conﬁrm the size of the amplicon.
The gel was visualized under UV radiation in a Camag
Reprostar (Camag, Muttenz, Switzerland) and image cap-
tured (Canon, Tokyo, Japan). Each experiment was repe-
ated at least three times with all available accessions
(Table 1) of each plant species to conﬁrm its reproduc-
ibility and repeatability.
Direct sequencing of complete ITS region
PCR ampliﬁed complete ITS region of B. aristata, B. asi-
atica and B. lycium were puriﬁed from agarose gel using
QIAquick gel extraction kit (Qiagen, Maryland, USA)
following manufacturer’s instruction. Direct sequencing of
the amplicon was done using primers ITS5 and ITS4 in an
automated ABI 3100 Genetic Analyser (Applied Biosys-
tems, CA, USA) by Bangalore Genei (Bangalore, India).
Sequence analysis and development of species-speciﬁc
markers for B. aristata, B. asiatica and B. lycium
Sequence boundaries of the ITS1, 5.8S and ITS2 were
determined following the submitted sequence data avail-
able on GenBank (http://www.ncbi.nlm.nih.gov/). The
complete sequence of the ITS region for each species
studied was then deposited at GenBank. Multiple align-
ment was done with complete ITS sequences of B. aristata,
B. asiatica and B. lycium, employing CLUSTALW
(http://www.ebi.ac.uk.clustalw/). Homology percentage
was calculated using the following formula:
Homology % ¼
Number of homologous bases in the species compared
Total Number of bases in the species compared with
  100
DNA primers capable of giving speciﬁc ampliﬁcation
with individual species were developed using NCBI primer
blast tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
The oligonucleotides were custom synthesized by Bioserve
biotechnologies (Hyderabad, India). PCR reaction with the
species-speciﬁc primer set contained 30 ng of genomic
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dNTP mix, 30 pM of each primer and 1 U of Taq DNA
polymerase (Bangalore Genei, India) with the volume
made up to 25 ll with sterile distilled water. PCR program
conditions optimized for the species-speciﬁc primer sets
were as follows: 94 C for 4 min, followed by 35 cycles of
35 s at 94 C, 30 s at 60 C and 45 s at 72 C with a ﬁnal
extension step for 3 min at 72 C.
Results
Extraction of genomic DNA and ampliﬁcation
of complete ITS sequence
After trying with many reported DNA extraction protocols,
the method described in ‘‘Materials and methods’’ section
repeatedly yielded good quality, high molecular weight
genomic DNA from the dried stem samples of B. aristata,
B.asiaticaandB.lycium.Theprocedureyielded400–600 ng
of DNA per 100 mg of tissue. An absorbance (A260/A280)
ratio of 1.6–1.8 indicated insigniﬁcant levels of contami-
nating proteins and polysaccharides. The universal primers
ITS5 (forward) and ITS4 (reverse) ampliﬁed the complete
ITS region (ITS1, 5.8S rRNA gene and ITS2) yielding an
amplicon of approximately 700 bp for all the three species
studied (Fig. 1).
Sequencing of complete ITS region and homology
analysis
Direct sequencing of the gel puriﬁed amplicon yielded a
652 bp sequence for B. aristata (GeneBank accession no.
GQ259132) (Fig. 2a), 678 bp for B. asiatica (GeneBank
accessionno.GQ259133)(Fig. 2b)and765 bpforB.lycium
(GeneBank accession no. GQ259134) (Fig. 2c). BLAST
analysis indicated that the sequences were novel. Multiple
alignmentofrRNAandITSsequenceofBerberisspp.under
studyrevealedinter-speciessequencevariation(Fig. 3).The
homology score in the ITS1, 5.8S rRNA gene and ITS2
regions of B. aristata,B. asiatica and B. lycium are shown in
Table 2. Interestingly, the data from sequence alignment
indicatedthattheITS1,5.8SrRNAgeneandITS2regionsof
eachspecieswerequiteuniqueanddifferentfromeachother.
Maximum homology was observed in the ITS1 regions of
B. asiatica and B. lycium (97.86%) while lowest (56.41%)
was seen in the ITS1 regions of B. asiatica and B. aristata
(Table 2). The sequence variation was used to develop
species-speciﬁc markers for individual species.
Designing of species-speciﬁc markers and validation
NCBI primer blast tool was used to develop and validate
the species-speciﬁc markers. The details of species-speciﬁc
primers designed and amplicon size are given in Table 3.
The B. aristata-speciﬁc primers (AR1F and AR1R) yielded
405 bp amplicon with all the accessions of B. aristata only
and did not produce any ampliﬁcation with B. asiatica and
B. lycium (Fig. 4). Similarly, primers AS1F and AS1R
produced ampliﬁcation (401 bp) only with B. asiatica
accessions (Fig. 5), while BL2F and BL2R primers yielded
232 bp amplicon only with B. lycium samples (Fig. 6).
Discussion
One of the impediments in the acceptance of herbal for-
mulations is the lack of standardization and quality control
proﬁles. Due to the complex nature and inherent variability
of the chemical constituents of plant-based drugs, it is
difﬁcult to establish quality control parameters using phy-
tochemical tools (World Health Organization 2000). The
pitfalls associated with the common conventional Phar-
macognosy methods like macro-microscopic examination
and phytochemical analysis have led to the search of
deﬁnitive methods for authentication of herbs and formu-
lations (Yan-Bo et al. 2007). Chinese pharmacopoeia has
already started including modern DNA-based details to
distinguish herbs (Yip et al. 2007).
Our experience with B.aristata, B. asiatica and B. ly-
cium indicates that they can hardly be distinguished based
on their morphology and histology (data unpublished).
Controversial reports on the berberine content of these
three species have been reported in the past. A comparative
high performance thin layer chromatography (HPTLC)
analysis of B. asiatica with B. aristata showed identical
proﬁle with lesser berberine content in the former
(Srivastava et al. 2004). While, Andola et al. (2010) have
reported that B. asiatica has higher berberine content fol-
lowed by B. lycium and B. asiatica. These inconsistent
reports indicate the disadvantage of chemical marker and
also insist on a robust technique for differentiating these
three species.
Fig. 1 PCR ampliﬁcation of complete ITS sequence. Lane M 100 bp
DNA ladder; lanes 1–3 B. aristata; lanes 4–6 B. asiatica; lanes 7–9
B. lycium. Approximately, 700 bp amplicon can be observed with all
samples of Berberis spp.
14 3 Biotech (2011) 1:11–19
123Fig. 2 Complete ITS sequence
of B. aristata, B. asiatica and B.
lycium. Species-speciﬁc 20 mer
primers (forward and reverse)
for each species is shown
underlined in the sequence
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the complete ITS sequence of
B. aristata, B. asiatica and
B. lycium
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like randomly ampliﬁed polymorphic DNA (RAPD),
restriction fragment length polymorphism (RFLP) and
ampliﬁed fragment length polymorphism (AFLP) have poor
reproducibility of markers (Yan-Bo et al. 2007). Recently,
more reproducible sequence characterized ampliﬁed region
(SCAR) markers have been developed for many medicinal
plant species to distinguish from their substitutes or adul-
terants (Devaiah and Venkatasubramanian 2008; Devaiah
et al. 2010). Many studies in recent years have employed
ITS sequences as genetic markers for various species at
generic and intrageneric levels. The length and sequences of
ITS regions of ribosomal RNA gene repeats are believed to
rapidly turn over thus capturing measurable variations
between species (Dubouzet and Shinoda 1999). Universal
PCR primers designed from highly conserved regions
ﬂanking the ITS region, relatively small in size
Table 2 The Homology Score in the ITS Region of B. aristata, B. asiatica and B. lycium
B. aristata B. asiatica B. lycium
ITS1 5.8S ITS2 ITS1 5.8S ITS2 ITS1 5.8S ITS2
B. aristata
ITS1 –––67.00% ––72.08% ––
5.8S ––––82.89% ––72.36% –
ITS2 –––––84.86% ––80.27%
B. asiatica
ITS1 56.41% –––––97.86% ––
5.8S – 83.56% –––––78.76% –
ITS2 ––86.72% –––––74.88%
B. lycium
ITS1 60.94% ––99.14% –––––
5.8S – 75.34% ––79.45% ––––
ITS2 ––78.44% ––72.47% –––
Table 3 Details of the species-speciﬁc markers designed using the ITS sequence
Plant species Name of the marker Sequence of the DNA marker (50? 30) Product (bp) size
B. aristata AR1F TCTCGCTCTGATAAATACAACTCG 405
AR1R CGTCAACAGGCAAACACGAC
B. asiatica AS1F GTACAAGGTTTCCGTAGGTGAACT 401
AS1R GTGCCTCAGCCTAGTGGTTTG
B. lycium BL2F TTCGACAAGGTTTCCGTAGG 232
BL2R AGAGCAAGGGGCAAGCTACT
Fig. 4 PCR ampliﬁcation of genomic DNA from Berberis spp. with
AR1F and AR1R. Lane M 100 bp DNA ladder; lanes 1–5 B. aristata;
lanes 6–8 B. asiatica; lanes 9–11 B. lycium. A 405 bp amplicon is
observed only in B. aristata samples
Fig. 5 PCR ampliﬁcation of genomic DNA from Berberis spp. with
AS1F and AS1R. Lane M 100 bp DNA ladder; lanes 1–4 B. asiatica;
lanes 5–7 B. lycium; lanes 8–10 B. aristata. A 401 bp amplicon is
observed only in B. asiatica samples
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easy ampliﬁcation of the ITS region (Yan-Bo et al. 2007;
Yip et al. 2007). These advantages have made ITS region
and ribosomal RNA gene sequence as preferred choice for
molecular typing. Novak et al. (2007) have reported ITS
sequence-based authentication of Echinacea spp. in
extracts. Balasubramani et al. (2010) have reported ITS
sequence-based DNA markers to differentiate Tribulus spp.
of the Zygophyllaceae family. Watthanachaiyingcharoen
et al. (2010) have reported 18S rRNA gene-based PCR–
RFLP to distinguish Coscinium fenestratum from other
genus in the Menispermaceae family.
The main problem with DNA-based methods for iden-
tiﬁcation is the presence of phenolic compounds, acidic
polysaccharides and pigments that hinder the PCR ampli-
ﬁcation. This can be avoided by choosing the most suitable
DNA extraction process that helps to eliminate the PCR
inhibitors. DNA-based methods have been successfully
used to even authenticate herbal constituents in commercial
herbal preparations in which the components have been
ground, boiled, concentrated, dried and blended (Yip et al.
2007). DNA information may not be directly correlated
with the amounts of the active ingredients and this is one
disadvantage.
In this study, we have described ITS sequence-based
efﬁcient and reliable DNA markers to identify and distin-
guish B. aristata, B. asiatica and B. lycium. These markers
can be used as a molecular pharmacognostic tool for
quality control of herbal raw drugs.
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